Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 trial of rVSVΔG-LASV-GPC vaccine in healthy adults
PACTR202106625781067Phase 1Completed
- Sponsor
- International AIDS Vaccine Initiative
- Start
- Jun 2021
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial in Lassa fever, sponsored by International AIDS Vaccine Initiative. Started Jun 2021; status: completed.
02
Conditions
Lassa fever
Beyond the preview
Go deeper on PACTR202106625781067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202106625781067.